Division of Cardiology, Department of Cardiology, Loyola University Medical Center, Maywood, Illinois, USA.
Department of Medicine, Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois, USA.
Catheter Cardiovasc Interv. 2023 Oct;102(4):569-576. doi: 10.1002/ccd.30792. Epub 2023 Aug 7.
Acute myocardial infarction complicated by cardiogenic shock (AMI-CS) is the most common cause of mortality following AMI, and treatment algorithms vary widely. We report the results of an analysis using time-sensitive, hemodynamic goals in the treatment of AMI-CS in a single center study.
Consecutive patients with AMI-CS from November 2016 through December 2021 were included in our retrospective analysis. Clinical characteristics and outcomes were analyzed using the electronic medical records. We identified 63 total patients who were admitted to our center with AMI-CS, and we excluded patients who did not have clear timing of AMI onset or CS onset. We evaluated the rate of survival to hospital discharge based on the quantity of certain time-sensitive hemodynamic goals were met.
We identified 63 patients who met criteria for AMI-CS, 39 (62%) of whom survived to hospital discharge. Odds of survival were closely related to the achievement of four time-dependent goals: cardiac power output (CPO) >0.6 Watts (W), pulmonary artery pulsatility index (PAPi) >1, lactate <4 mmol/L, and <2 vasopressors required. Of the 63 total patients, 36 (57%) received intra-aortic balloon pump (IABP) and 18 (29%) received an Impella CP (Abiomed) as an initial mechanical circulatory support strategy. Six patients were escalated from IABP to Impella CP for additional hemodynamic support. Nine patients were treated with vasopressors/inotropes alone. Regarding the 39 patients who survived to hospital discharge, 75% of patients met 3 or 4 goals at 24 h, whereas only 16% of deceased patients met 3 or 4 goals at 24 h. Of the 24 patients who did not survive to hospital discharge, 18 (75%) met either 0-1 goal at 24 h. There was no effect of the initial treatment strategy on achieving 3-4 goals at 24 h.
Our study evaluated the association of meeting 4 time-sensitive goals (CPO >0.6 W, PAPi >1, <2 vasopressors, and lactate <4 mmol/L) at 24 h after treatment for AMI-CS with in-hospital mortality. Our data show, in line with previous data, that the higher number of goals met at 24 h was associated with improved in-hospital mortality regardless of treatment strategy.
急性心肌梗死并发心源性休克(AMI-CS)是 AMI 后最常见的死亡原因,治疗方案差异很大。我们报告了在单中心研究中使用时间敏感的血流动力学目标治疗 AMI-CS 的分析结果。
回顾性分析 2016 年 11 月至 2021 年 12 月期间因 AMI-CS 入院的连续患者。使用电子病历分析临床特征和结局。我们确定了 63 名因 AMI-CS 入住我院的患者,排除了 AMI 发病或 CS 发病时间不明确的患者。我们根据满足某些时间敏感血流动力学目标的数量评估了住院期间的生存率。
我们确定了 63 名符合 AMI-CS 标准的患者,其中 39 名(62%)存活至出院。存活的可能性与四项时间依赖性目标的实现密切相关:心输出功率(CPO)>0.6 瓦特(W)、肺动脉搏动指数(PAPi)>1、乳酸<4mmol/L 和需要<2 种血管加压药。在 63 名患者中,36 名(57%)接受了主动脉内球囊泵(IABP)治疗,18 名(29%)接受了 Impella CP(Abiomed)作为初始机械循环支持策略。6 名患者因需要额外的血流动力学支持而从 IABP 升级为 Impella CP。9 名患者仅接受血管加压药/正性肌力药治疗。在 39 名存活至出院的患者中,75%的患者在 24 小时时满足 3 或 4 个目标,而死亡患者中只有 16%在 24 小时时满足 3 或 4 个目标。在 24 名未存活至出院的患者中,18 名(75%)在 24 小时时满足 0-1 个目标。初始治疗策略对 24 小时时满足 3-4 个目标没有影响。
我们的研究评估了在 AMI-CS 治疗后 24 小时满足 4 个时间敏感目标(CPO>0.6W、PAPi>1、<2 种血管加压药和乳酸<4mmol/L)与住院死亡率的关系。我们的数据表明,与之前的数据一致,无论治疗策略如何,24 小时时满足的目标数量越多,住院死亡率越低。